“Assessment of Neuregulin4 function in patients with polycystic ovary syndrome disorder”, Journal of Pharmaceutical Negative Results, vol. 13, no. 4, pp. 676–678, Oct. 2022, doi: 10.47750/pnr.2022.13.04.090.